Inventor · disambiguated record
Alan S. Krasner
Also filed as: KRASNER ALAN S
1 granted patent·7 pending applications·0 citations·filing 2001–2025
14Inventor score
Files withCRINETICS PHARMACEUTICALS INC6
Top patents by PatentIndex Score
8 records- 0164US2024366587A1Uses of a somatostatin modulator for the treatment of diseaseCRINETICS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0257US2022387420A1Uses of a somatostatin modulator for the treatment of diseaseCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0353US12280046B2Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of diseaseCRINETICS PHARMACEUTICALS INC·Filed 2022·Granted Apr 22, 2025·0 cites·18 claims
- 0445US2025367190A1Melanocortin subtype-2 receptor (mc2r) antagonist for the treatment of diseaseCRINETICS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0543US2025228842A1Uses of a somatostatin modulator for the treatment of carcinoid syndromeCRINETICS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0641US2022323427A1Somatostatin receptor type 5 agonist for the treatment of hyperinsulinismCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0725US2002164267A1Method of preventing type 2 diabetes with aerosolized insulinFiled 2002·Application pending·0 cites
- 0815US2002123513A1Use of glycogen phosphorylase inhibitors to inhibit tumor growthFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan S. Krasner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →